Ponvilawan Ben, Sakornsakolpat Phuwanat, Pongpaibul Ananya, Roothumnong Ekkapong, Akewanlop Charuwan, Pithukpakorn Manop, Korphaisarn Krittiya
Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.
BMC Cancer. 2025 Feb 25;25(1):349. doi: 10.1186/s12885-025-13745-5.
The incidence of colorectal cancer (CRC) in young adults has increased worldwide. Our study aimed to evaluate genomic alterations in early-onset (aged 15-39 years) sporadic CRC.
Formalin-fixed, paraffin-embedded tissue samples from 90 patients with histologically confirmed colorectal adenocarcinoma with proficient mismatch repair status from Siriraj Hospital (Bangkok, Thailand) were extracted. Patients with clinically suspected familial adenomatous polyposis were excluded. A 517-gene mutational analysis was performed by next-generation sequencing using the Oncomine Comprehensive Assay Plus kit. The previously reported molecular data in adult-onset CRC from our group were used as a comparator group.
The five most frequently mutated genes were APC (66%), TP53 (51%), KRAS (47%), ARID1A (31%), and KMT2B (31%). When compare with adult-onset, NOTCH1 (11.1% vs. 1.9%), FBXW7 (23.3% vs. 14.8%), PIK3CA (20% vs. 12.1%), and FGFR3 (8.9% vs. 3.7%) mutations were more prevalent in early-onset. No differences were observed in other common mutations, such as TP53, EGFR, KRAS, NRAS and BRAF mutations. An increased prevalence in KRAS codon 12 mutations was also observed in early-onset patients compared to the adult-onset group (38.9% vs. 29.6%).
Overall, the genomic landscape between early- and adult-onset CRC appears similar. However, our study revealed the enrichment of NOTCH1, FBXW7, PIK3CA, and FGFR3 along with KRAS G12 mutations, were more frequent in early-onset compared to adult-onset cases. Further studies with a larger cohort of patients on the comprehensive analysis of genetic/epigenetic signatures are required.
全球范围内,年轻成年人结直肠癌(CRC)的发病率呈上升趋势。我们的研究旨在评估早发性(15 - 39岁)散发性结直肠癌的基因组改变。
从泰国曼谷诗里拉吉医院提取90例组织学确诊为结直肠腺癌且错配修复功能正常的患者的福尔马林固定、石蜡包埋组织样本。排除临床疑似家族性腺瘤性息肉病患者。使用Oncomine Comprehensive Assay Plus试剂盒通过二代测序进行517基因的突变分析。将我们团队之前报道的成年发病型结直肠癌的分子数据用作对照。
最常发生突变的五个基因是APC(66%)、TP53(51%)、KRAS(47%)、ARID1A(31%)和KMT2B(31%)。与成年发病型相比,NOTCH1(11.1%对1.9%)、FBXW7(23.3%对14.8%)、PIK3CA(20%对12.1%)和FGFR3(8.9%对3.7%)突变在早发性中更为普遍。在其他常见突变中未观察到差异,如TP53、EGFR、KRAS、NRAS和BRAF突变。与成年发病组相比,早发性患者中KRAS密码子12突变的患病率也有所增加(38.9%对29.6%)。
总体而言,早发性和成年发病型结直肠癌的基因组格局似乎相似。然而,我们的数据显示,与成年发病型病例相比,NOTCH1、FBXW7、PIK3CA和FGFR3以及KRAS G12突变在早发性中更频繁。需要对更多患者队列进行进一步研究,以全面分析遗传/表观遗传特征。